Bisoprolol in cardiovascular disease treatment
Literature data are presented on the role of beta-adrenoblockers (BAB) and bisoprolol, in particular, in the treatment of cardiovascular disease (CVD), including coronary heart disease (CHD), chronic heart failure, arterial hypertension (AH) and cardiac arrhythmias. The main clinical trials, proving...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Russo |
| Vydáno: |
«SILICEA-POLIGRAF» LLC
2008-12-01
|
| Edice: | Кардиоваскулярная терапия и профилактика |
| Témata: | |
| On-line přístup: | https://cardiovascular.elpub.ru/jour/article/view/1689 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|